What are its benefits?

The Cardiovascular Genescreen can distinguish between high-risk individuals who require long-term medical treatment and those at increased risk of CVD and related disorders due to less severe gene-environment interactions. By identifying multiple risk factors that may interact with each other to increase the risk, a cumulative effect leading to disease development or progression could be prevented through targeted intervention. Although the CVD test is performed only once in a lifetime, it provides lifelong information on risk factors that may be more predictive of future risk or clinical outcome than conventional assessments. It also determines larger than average fluctuation in risk factor levels in certain environments.